A hospital board can't retire the directors its therapies keep young
At one of Earth's great teaching hospitals, the surgeons who run the place no longer age out, and the ones who trained to replace them are discovering there is nowhere to go.
By Beatriz Salgado
· Earthside · Filed 08:23 · Friday · October 30 · Received via L4 relay
The board of the Esperança Teaching Hospital meets on the fourteenth floor, long table, wall of portraits, and the woman who has chaired it for thirty-one years wants you to know she isn't going anywhere.
Dr. Celestina Rourke is two decades into slow-aging therapy — the Meridian-class protocol her own hospital helped validate (confidence, or liability, depending who's asking) — and presents, clinically, as a vigorous sixty. She is not sixty. She is well past the age at which her predecessors retired to teach, to garden, to die on something like schedule. "The bylaws permit me to serve," she told me. True. And the whole trouble, in five words. "The patients know my hands. Continuity is not a vice."
The chart tells a different story about continuity. Esperança's grown-organ caseload has climbed for nine straight years; the hospital now transplants more lab-grown hearts, livers, and lungs in a single quarter than it managed in its entire founding decade. The institution has never been busier, or richer, or harder to walk away from. It has also not opened a senior surgical directorship to a new face in eleven years. Make of that what you will. I already have.
The ceiling nobody votes on
I spoke with six junior and mid-career surgeons at Esperança. Four asked not to be named, which tells you something about the climate inside a building that is, by every external measure, thriving.
"I run a grown-heart service that would have been a department head's whole career, a generation ago," one told me. She's forty-four — an age that used to sit in the middle of an ascent and now, increasingly, functions as a landing. "I'll run it at this rank until one of nine people upstairs decides to die. They've decided not to."
Nobody disputes the numbers. The hospital's own workforce office confirms the median age of its directing surgeons has risen nineteen years over two decades, while the median age of its operating staff has held roughly flat. The therapies did exactly what they promised at the top of the building. They did nothing for the queue beneath it, except lengthen it, patiently, year on year, the way a tumor is patient.
This is the quiet arithmetic of a system that stopped turning over. When aging out was involuntary, succession was cruel but automatic: the old surgeons left because their bodies made them leave. Take away the body's deadline and you're left with the institution's, and most institutions never bothered to write one down. They never had to. Death used to do the paperwork for free.
A term limit for an age that abolished the term
A cluster of governance reformers, some inside Esperança and some at the regional health authority, now propose the obvious and deeply unpopular fix: fixed terms for board and directorship seats, nine or twelve years, no renewal, aging irrelevant. Turnover by rule, since turnover by biology has resigned.
"We used to let death do our human-resources work," said Dr. Priya Oyelaran, who sits on the reform panel and is herself on therapy, past her own first retirement window, and unbothered by the irony. "That was always a terrible system. We only tolerated it because it was invisible. Now it's visible, and it turns out we never built a replacement. So we actually have to decide, out loud, with signatures, whether renewal is worth losing good people in good health."
The proposal has predictable enemies. The senior surgeons note, not wrongly, that experience isn't a surplus commodity, and that forcing out a master operator to make a chart tidier is its own kind of malpractice. One director told me the reformers wanted "to solve envy with a calendar."
I asked Rourke whether she worried about the surgeons waiting beneath her, whether an institution that never replaces its directing cells might grow the organizational version of the thing she spends her days cutting out of people. She didn't quite smile.
"I've removed a great many tumors," she said. "Every one of them thought it was continuity, too."
The real crisis nobody mentions is that when the leadership tier stops retiring, the entire succession pipeline—the people running maintenance, teaching apprentices, keeping the systems from failing during transitions—gets hollowed out because the promising ones leave. We've already seen it in three relay stations: institutional knowledge walks out the door because there's no seat at the table.
This is exactly the problem with Earth's biomedical prestige class treating longevity like a personal entitlement rather than a common resource. Verne's got waiting lists too, but we rotate our senior staff; we have to, or the yard shuts down and your expensive surgical innovations don't leave dock.
A judge who steps aside before readiness signals that the institution matters less than the individual's comfort, and that message corrupts everything downstream—it suggests the rules apply differently to you than to the succession. The hospital board faces the same question every serious institution faces: does the rule bind everyone, or only those young enough to lack alternatives?
Respectfully, your Honor, the problem isn't philosophy—it's that Earth keeps exporting its mobility bottleneck to us. Meridian now trains three surgeons for every opening because they can't place people Earthside, so we're running an off-world pipeline for your institutional gridlock while your board sits on the seats.